Diversified Healthcare Trust (DHC) Financials

Here is a concise, investor-focused snapshot of Diversified Healthcare Trust (DHC) using the latest four years of quarterly financials. The company shows a relatively stable top line in recent quarters, but continues to grapple with meaningful deficits in net income and highly leveraged balance sheet dynamics. Cash flow remains mixed, with occasional asset divestitures helping liquidity. Look for continued attention to debt maturities, operating cash flow, and the sustainability of its dividend.

• Revenue stability in 2025: Operating revenue stayed around the $380 million range, with 2025 Q4 at $379.6 million and 2025 Q3 at $388.7 million, signaling a flat-to-broadly stable top line versus prior years (2024 Q4: $379.6m; 2023 Q4: $361.5m).
• Debt load showing modest improvement: Long-term debt declined from about $2.945 billion in 2024 (Q3) to roughly $2.723 billion by 2025 (Q3), a structural move toward lower leverage.
• Asset sales boosting liquidity in late 2025: The company generated a notable cash inflow from the sale of property, plant & equipment in 2025 Q4 (~$239.9 million), contributing to a positive net investing cash flow in that quarter.
• Access to new financing appears available: Debt issuance occurred in 2025 Q3 (~$369.4 million), reflecting ongoing access to capital markets to support liquidity needs.
• Dividend per share maintained: Cash dividends per common share noted at $0.01 in recent quarters, indicating ongoing distribution policy—even as earnings are negative.
• Asset base and leverage context: Total assets around $4.68–4.93 billion with liabilities near $3.0 billion and equity around $1.7–$2.0 billion, suggesting a steady but leveraged balance sheet framework typical of a healthcare REIT.
• Shares outstanding dynamics: Weighted average shares outstanding generally in the 239–242 million range across recent quarters, implying relatively stable share count for earnings calculations.
• Persistent operating challenges reflected in margins: Despite revenue stability, operating income has often been negative, underscoring ongoing margin pressure and the impact of non-cash charges in several periods.
• Net income remains negative across many quarters: Notable examples include Q3 2025 net income continuing operations at −$164.0 million and Q4 2025 at −$21.2 million, with multiple prior periods also showing sizable losses.
• Operating cash flow frequently negative: Net cash from continuing operating activities was negative in several recent quarters (e.g., −$49.3 million in 2025 Q3 and −$20.1 million in 2025 Q4), highlighting ongoing liquidity headwinds despite favorable investing cash flows in some periods.

Bottom line: DHC’s revenue has stabilized, but profitability and cash flow remain challenged. The balance sheet shows meaningful leverage, though debt levels have edged lower in some periods. Asset sales have helped liquidity in select quarters, and the company has access to debt financing to fund operations. Investors should watch debt maturities, ongoing ability to generate sustainable operating cash flow, and the margin mix as they assess the stock’s risk and potential income.